Global $50+ Billion Biobanks Market Opportunities and Strategies to 2023 -

DUBLIN--()--The "Biobanks Global Market Opportunities And Strategies To 2023" report has been added to's offering.

The biobanks market reached a value of nearly $50.3 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 6.4% to nearly $68.5 billion by 2023.

Global Biobanks Market Opportunities And Strategies To 2023 provides the strategists, marketers and senior management with the critical information they need to assess the global biobanks market.

Where is the largest and fastest growing market for the biobanks market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biobanks market opportunities and strategies to 2023 report from the author answers all these questions and many more.

This report analyses and evaluates the biobanks market, which consists of sales of biological specimens such as blood products, human tissues, cell lines nucleic acids (DNA, RNA) and other specimens through biorepositories. The report covers two periods - 2014 to 2018, the historic period and 2018 to 2023, the forecast period.

Factors such as advances in drug discovery and development, rise in funding from government and private organizations, changes in lifestyle and increasing geriatric population globally are contributing to the growth of the market. Factors such as such as stringent regulations, lack of standardization and ethical and legal issues such as informed consent and protection of participant privacy may restrain the growth of the biobanks market.

The blood products segment accounted for the largest share of the biobanks market in 2018 at $38.1 billion. The highest growth is projected to come from the human tissues and cells segment, which is forecast to grow at a CAGR of 12.3%. This growth was mainly due to greater use of blood products such as plasma and platelets for treating medical conditions and for medical research.

North America was the largest region in the biobanks market in 2018, accounting for 46.8% of the global market. It was followed by Western Europe and Asia Pacific. Going forward, the fastest growth in the biobanks market will take place in Asia Pacific, where it is forecast to grow at a CAGR of 11.1%, followed by South America where growth at a CAGR of 9.3% is expected.

The USA is the largest country in terms of value in the biobanks market. India and China are forecast to have the fastest growth, rising at CAGRs of 14.2% and 13.7% respectively.

Major players in the market include Japanese Red Cross Society (JRCS), American Red Cross, Canadian Blood Services, Biobank Graz, Shanghai Zhangjiang Biobank and others.

Major opportunities in the biobanks market will arise in the USA, where the market will gain $4,543 million in annual sales between 2018 and 2023, in China, where it will put on $3,488 million and globally, where the blood products segment will accrue $10,385 million of extra revenues in that period. To take advantage of such opportunities, biobank businesses should adopt strategies such as developing virtual banks to speed up the accessibility of biospecimens and clinical data, implementing radio frequency identification (RFID) technology to automate biospecimen sample tagging and tracking and help reduce costs and errors and building resource centers of biological samples for major diseases.

Key Topics Covered:

1. Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

7. Biobanks Market Characteristics

8. Biobanks Market - Supply Chain

9. Biobanks Market Industry Trends and Strategies

9.1.1.Development of Virtual Biobanks

9.1.2.Radio Frequency Identification (RFID) for Sample Tracking

9.1.3.Automated Sample Storage and Liquid Handling Systems in Biobanks

9.1.4.Use of Dry Storage as an Alternative by Biobanks

9.1.5.Use of Internet of Things (IOT) and Big Data Analytics in Biobanks

9.1.6.Increase in Collaborations and Partnerships

10. Biobanks Market Size and Growth

10.1. Historic Market Growth

10.2. Drivers of the Market

10.3. Restraints on the Market

10.4. Drivers of the Market

10.5. Restraints on the Market

11. Biobanks Market Regional and Country Analysis

11.1. Global Biobanks Market, By Region

11.2. Global Biobanks Market, 2014-2023, Historic and Forecast, By Region

11.3. Global Biobanks Market, By Country

11.4. Global Biobanks Market, 2014-2023, Historic and Forecast, By Country

12. Biobanks Market Segmentation

12.1. Global Biobanks Market, 2018, By Segment, Value ($ Billion)

12.2. Global Biobanks Market, 2014-2023, Historic and Forecast, By Segment

13. Global Biobanks Market Comparison with Macro Economic Factors

13.1. Global Per Capita Average Biobanks Market Expenditure

13.2. Per Capita Average Biobanks Market Expenditure, By Country

13.3. Global Biobanks Market Size, Percentage of GDP

13.4. Biobanks Market Size, Percentage of GDP, By Country

14. Asia-Pacific Biobanks Market

15. Western Europe Biobanks Market Overview

16. Eastern Europe Biobanks Market Overview

17. North America Biobanks Market Overview

18. South America Biobanks Market Overview

19. Middle East Biobanks Market Overview

20. Africa Biobanks Market Overview

21. Biobanks Market Competitive Landscape

21.1. Company Profiles

21.2. Japanese Red Cross Society

21.3. American Red Cross

21.4. Canadian Blood Services

21.5. Biobank Graz

21.6. Shanghai Zhangjiang Biobank

22. Key Mergers And Acquisitions In The Biobanks Market

22.1. Grifols Acquired Minority Stake in Interstate Blood Bank

22.2. Cryo-Cell International Acquired Cord: Use Cord Blood Bank

22.3. BioDuro Acquired Molecular Response, LLC

22.4. Roche Acquired Signature Diagnostics

22.5. Lifeblood Merged With Blood Systems

23. Market Innovations

23.1.1. Use of 3D Printing technology

23.1.2. Digitalization of biobanks

24. Opportunities And Strategies

24.1. Global Biobanks Market Opportunities

24.2. Global Biobanks Market In 2023- Countries Offering Most New Opportunities

24.3. Global Biobanks In 2023- Segments Offering Most New Opportunities

24.3.1. Blood Products

24.3.2. Cell Lines

24.3.3. Human Tissues and Cells

24.3.4. Nucleic Acids

24.4. Global Biobanks Market Strategies In 2023 - Growth Strategies

24.4.1. Market Trend Based Strategies

Companies Mentioned

  • American Red Cross
  • BioDuro
  • Biobank Graz
  • Blood Systems
  • Canadian Blood Services
  • Cryo-Cell International
  • Grifols
  • Interstate Blood Bank
  • Japanese Red Cross Society
  • Lifeblood
  • Molecular Response, LLC
  • Roche
  • Shanghai Zhangjiang Biobank
  • Signature Diagnostics

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology

Laura Wood, Senior Press Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biotechnology